Investigational Study for Small Cell Lung Cancer Patients Using Radiation
Seeking Men and Women 18 years or older who have small cell lung cancer, which can spread to the brain.
9 Studies found
Lung Cancer
Lung Cancer
Lung Cancer Study Involving Radiation Treatment
This study is looking at a new investigational treatment for small cell lung cancer that has not been detected outside of the chest.
Lung Cancer
Experimental Study for Treating Patients With Non-small Cell Lung Cancer (Alchemist)
Seeking Men and Women over 18 years old who have early stage non-small cell lung cancer that was surgically removed and may have been treated with chemotherapy and/or radiation. The tumor removed has a mutation of a gene called EGFR (Epidermal Growth Factor Receptor).
Lung Cancer
Study for Patients With Early Stage Non-small Cell Lung Cancer (Alchemist 4512)
Seeking adult men & women whose tumor cells have a change in a gene called ALK that causes the cells to grow and spread.
Lung Cancer
Pre-Surgery Therapy Study for Non-Small Cell Lung Cancer
Seeking Men & Women 18 years or older who have previously untreated stages IIB - IIIA Non-Small Cell Lung Cancer (NSCLC).
Lung Cancer
Investigational Drug Study, Involving Radiation for Patients with Lung Cancer.
Seeking Men and Women over 18 years old who have a certain type of Stage III Non-Small Cell Lung Cancer (NSCLC).
Lung Cancer
Study Of Using Tumor Biomarkers To Guide Treatment For Non-Small Cell Lung Cancer
Seeking adults with non-small cell lung cancer for a study comparing immunotherapy to targeted therapy based on tumor characteristics
Lung Cancer
Study Of An Investigational Drug For Non-Small Cell Lung Cancer That Has Spread
People with non-small cell lung cancer that has spread outside their lungs and whose tumor has a particular biomarker are sought for a study of an investigational drug.
Lung Cancer
Study Of An Investigational Drug For Previously Treated Non-Small Cell Lung Cancer
Seeking volunteers who received immunotherapy, but whose non-small cell lung cancer has spread outside their lungs and either their tumor sample biomarker does not match one of the open treatment studies or they were not a candidate for a biomarker-matched study for a study of an investigational drug combination.